From Casetext: Smarter Legal Research

In re Aimmune Therapeutics, Inc. Sec. Litig.

United States District Court, Northern District of California
Jun 6, 2024
20-cv-06733-MMC (N.D. Cal. Jun. 6, 2024)

Opinion

20-cv-06733-MMC

06-06-2024

IN RE AIMMUNE THERAPEUTICS, INC. SECURITIES LITIGATION


ORDER DENYING LEAVE TO EXCEED PAGE LIMITS FOR SUMMARY JUDGMENT BRIEFING

MAXINE M. CHESNEY, UNITED STATES DISTRICT JUDGE

Before the Court is the parties' “Stipulation and [Proposed] Order Granting Leave to Exceed Page Limits for Motion for Summary Judgment,” filed June 5, 2024, whereby the parties agree, subject to Court approval, their opening, opposition, and reply brief(s) may exceed by five pages the page limits set forth in the Local Rules of this District. Although, as the basis for such request, the parties rely, without further elaboration, on the “number and complexity of the legal issues that will be discussed,” the “significant amount of evidence,” and “over a dozen depositions,” the record of the case to date does not support a need for the requested extensions.

Accordingly, the parties' stipulation for leave is hereby DENIED.

IT IS SO ORDERED.


Summaries of

In re Aimmune Therapeutics, Inc. Sec. Litig.

United States District Court, Northern District of California
Jun 6, 2024
20-cv-06733-MMC (N.D. Cal. Jun. 6, 2024)
Case details for

In re Aimmune Therapeutics, Inc. Sec. Litig.

Case Details

Full title:IN RE AIMMUNE THERAPEUTICS, INC. SECURITIES LITIGATION

Court:United States District Court, Northern District of California

Date published: Jun 6, 2024

Citations

20-cv-06733-MMC (N.D. Cal. Jun. 6, 2024)